Neil Smith

Title: Neil Smith: Innovator in BH4-Related Disorders

Introduction

Neil Smith is a notable inventor based in Cary, NC (US), recognized for his contributions to the field of biochemistry and pharmacology. He holds a total of 3 patents, focusing on methods and compositions that address BH4-related disorders. His innovative work has the potential to significantly impact treatment options for patients suffering from these conditions.

Latest Patents

Among his latest patents, one includes "Methods for increasing sepiapterin plasma exposure." This invention features compositions that include sepiapterin, or a pharmaceutically acceptable salt thereof, aimed at treating BH4-related disorders. The methods described in this patent result in an increase in plasma, cerebrospinal fluid (CSF), and brain exposure of sepiapterin. Another significant patent is "Compositions and methods for increasing tetrahydrobiopterin plasma exposure." This invention also focuses on sepiapterin and its role in enhancing plasma exposure of BH4, further contributing to the treatment of BH4-related disorders.

Career Highlights

Neil Smith has worked with reputable organizations such as PTC Therapeutics, Inc. and Virginia Commonwealth University. His experience in these institutions has allowed him to collaborate with leading experts in the field and advance his research on BH4-related disorders.

Collaborations

Some of his notable coworkers include Jonathan Reis and Eleonora Mezzaroma. Their collaborative efforts have contributed to the development of innovative solutions in the realm of biochemistry.

Conclusion

Neil Smith's work in developing methods and compositions for treating BH4-related disorders showcases his dedication to innovation in the field. His patents reflect a commitment to improving patient outcomes through scientific advancements.